Wells Fargo & Company Issues Pessimistic Forecast for Omega Healthcare Investors (NYSE:OHI) Stock Price

Omega Healthcare Investors (NYSE:OHI) had its price target reduced by Wells Fargo & Company from $49.00 to $48.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 2.33% from the company’s previous close.

Several other research analysts also recently weighed in on OHI. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. Scotiabank dropped their price target on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Raymond James Financial started coverage on shares of Omega Healthcare Investors in a report on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 target price for the company. Truist Financial reduced their target price on Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating for the company in a report on Tuesday, June 9th. Finally, Mizuho boosted their price objective on Omega Healthcare Investors from $45.00 to $46.00 and gave the stock a “neutral” rating in a research report on Monday. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $49.50.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI traded up $1.19 during midday trading on Tuesday, reaching $46.91. The stock had a trading volume of 330,188 shares, compared to its average volume of 2,068,946. The firm has a market cap of $14.21 billion, a price-to-earnings ratio of 16.75, a price-to-earnings-growth ratio of 1.86 and a beta of 0.57. Omega Healthcare Investors has a twelve month low of $39.26 and a twelve month high of $52.39. The company’s 50 day moving average price is $48.36 and its 200 day moving average price is $47.10.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.68. The company had revenue of $328.25 million for the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The firm’s revenue was up 16.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. Equities analysts forecast that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Omega Healthcare Investors

Institutional investors have recently modified their holdings of the company. Royal Bank of Canada raised its position in Omega Healthcare Investors by 29.4% in the 1st quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock worth $5,496,000 after purchasing an additional 32,798 shares during the period. Focus Partners Wealth lifted its stake in shares of Omega Healthcare Investors by 3.1% in the 1st quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock valued at $756,000 after acquiring an additional 597 shares during the last quarter. Sivia Capital Partners LLC purchased a new stake in Omega Healthcare Investors during the 2nd quarter valued at about $257,000. Guggenheim Capital LLC grew its position in Omega Healthcare Investors by 1.0% during the 2nd quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock worth $1,077,000 after acquiring an additional 280 shares during the last quarter. Finally, First Trust Advisors LP increased its stake in Omega Healthcare Investors by 32.8% in the 2nd quarter. First Trust Advisors LP now owns 193,099 shares of the real estate investment trust’s stock worth $7,077,000 after purchasing an additional 47,649 shares during the period. 65.25% of the stock is currently owned by institutional investors.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.